GlassScriptPhysician profile
Lena Brar Chatterjee
NPI 1629752019
$3,288.44
in general payments reported to CMS, 2019-2025
10 companies · $1,124 in 2025
The $1,124 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,020 · 2024: $1,144 · 2025: $1,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,428 · Education: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.26 |
| Education | $860.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,191.97 | 2023-2025 | Endurant Iis |
| W. L. Gore & Associates, INC. | $783.06 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Boston Scientific Corporation | $636.76 | 2023-2025 | General - Vascular Intervention |
| Integra Lifesciences Corporation | $310.46 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medical Device Business Services, INC. | $107.69 | 2024 | |
| Cook Medical LLC | $100.30 | 2024 | Zenith Spiral-Z |
| Avita Medical Americas, LLC | $80.00 | 2024 | |
| Haemonetics Corporation | $36.95 | 2025 | Teg6s Hemostasis System |
| Solventum Corporation | $21.00 | 2024 | Activ.A.C. |
| Philips North America LLC | $20.25 | 2025 | Encore |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lena Chatterjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.